Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Condition:   Friedreich Ataxia Interventions:   Biological: CTI-1601;   Biological: Placebo Sponsor:   Chondrial Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials